-+ 0.00%
-+ 0.00%
-+ 0.00%

SAGIMET BIOSCIENCES AND TAPI ANNOUNCE GLOBAL LICENSE AGREEMENT FOR INNOVATIVE FORMS OF RESMETIROM API FOR SAGIMET’S FIXED DOSE COMBINATION PROGRAM

Reuters·12/17/2025 12:00:03

Please log in to view news